Distinguishing Imaging Features between Spinal Hyperplastic Hematopoietic Bone Marrow and Bone Metastasis

REFERENCES

1. 1.↵
   2. Mittra E,
   3. Quon A

   . Positron emission tomography/computed tomography: the current technology and applications. Radiol Clin North Am 2009;47:147–60

   CrossRefPubMed
2. 2.↵
   2. Cheng X,
   3. Li Y,
   4. Xu Z, et al

   . Comparison of ¹⁸F-FDG PET/CT with bone scintigraphy for detection of bone metastasis: a meta-analysis. Acta Radiol 2011;52:779–87

   Abstract/FREE Full Text
3. 3.↵
   2. Wu LM,
   3. Gu HY,
   4. Zheng J, et al

   . Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis. J Magn Reson Imaging 2011;34:128–35

   CrossRefPubMed
4. 4.↵
   2. Yang HL,
   3. Liu T,
   4. Wang XM, et al

   . Diagnosis of bone metastases: a meta-analysis comparing ¹⁸FDG PET, CT, MRI and bone scintigraphy. Eur Radiol 2011;21:2604–17

   CrossRefPubMed
5. 5.↵
   2. Vande Berg BC,
   3. Lecouvet FE,
   4. Galant C, et al

   . Normal variants and frequent marrow alterations that simulate bone marrow lesions at MR imaging. Radiol Clin North Am 2005;43:761–70, ix

   CrossRefPubMed
6. 6.↵
   2. Deutsch AL,
   3. Mink JH,
   4. Rosenfelt FP, et al

   . Incidental detection of hematopoietic hyperplasia on routine knee MR imaging. AJR Am J Roentgenol 1989;152:333–36

   CrossRefPubMed
7. 7.↵
   2. Shellock FG,
   3. Morris E,
   4. Deutsch AL, et al

   . Hematopoietic bone marrow hyperplasia: high prevalence on MR images of the knee in asymptomatic marathon runners. AJR Am J Roentgenol 1992;158:335–38

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Poulton TB,
   3. Murphy WD,
   4. Duerk JL, et al

   . Bone marrow reconversion in adults who are smokers: MR imaging findings. AJR Am J Roentgenol 1993;161:1217–21

   CrossRefPubMed
9. 9.↵
   2. Caldemeyer KS,
   3. Smith RR,
   4. Harris A, et al

   . Hematopoietic bone marrow hyperplasia: correlation of spinal MR findings, hematologic parameters, and bone mineral density in endurance athletes. Radiology 1996;198:503–08

   CrossRefPubMed
10. 10.↵
    2. Bordalo-Rodrigues M,
    3. Galant C,
    4. Lonneux M, et al

    . Focal nodular hyperplasia of the hematopoietic marrow simulating vertebral metastasis on FDG positron emission tomography. AJR Am J Roentgenol 2003;180:669–71

    CrossRefPubMed
11. 11.↵
    2. Ricci C,
    3. Cova M,
    4. Kang YS, et al

    . Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology 1990;177:83–88

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Amano Y,
    3. Hayashi H,
    4. Kumazaki T

    . Gd-DTPA enhanced MRI of reactive hematopoietic regions in marrow. J Comput Assist Tomogr 1994;18:214–17

    CrossRefPubMed
13. 13.↵
    2. Herneth AM,
    3. Philipp MO,
    4. Naude J, et al

    . Vertebral metastases: assessment with apparent diffusion coefficient. Radiology 2002;225:889–94

    CrossRefPubMed
14. 14.↵
    2. Elstrom RL,
    3. Tsai DE,
    4. Vergilio JA, et al

    . Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow. Clin Lymphoma 2004;5:62–64

    CrossRefPubMed
15. 15.↵
    2. Kaplan KR,
    3. Mitchell DG,
    4. Steiner RM, et al

    . Polycythemia vera and myelofibrosis: correlation of MR imaging, clinical, and laboratory findings. Radiology 1992;183:329–34

    CrossRefPubMed
16. 16.↵
    2. Daldrup-Link HE,
    3. Rummeny EJ,
    4. Ihssen B, et al

    . Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow. Eur Radiol 2002;12:1557–66

    CrossRefPubMed
17. 17.↵
    2. Tsukamoto N,
    3. Kojima M,
    4. Hasegawa M, et al

    . The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-PET with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification. Cancer 2007;110:652–59

    CrossRefPubMedWeb of Science